Welcome to our dedicated page for Castellum SEC filings (Ticker: CTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Castellum Inc’s rapid string of cybersecurity and electronic-warfare acquisitions means every new 10-K and 10-Q feels like a puzzle of contract clauses, backlog shifts, and earn-out schedules. If tracking cleared-executive sales or decoding fresh Department of Defense awards has you buried in PDFs, you’re not alone.
Stock Titan solves that problem. Our AI engine parses every Castellum Inc quarterly earnings report 10-Q filing and the sprawling annual report 10-K simplified into clear takeaways—think revenue by mission area, goodwill amortization, and pipeline updates without the jargon. Need Castellum Inc insider trading Form 4 transactions the moment they hit EDGAR? We deliver Form 4 insider transactions real-time, flag unusual buys, and link them to 8-K material events explained. You can even ask natural questions such as “understanding Castellum Inc SEC documents with AI” or “Castellum Inc proxy statement executive compensation” and receive instant, plain-English answers.
- Monitor Castellum Inc executive stock transactions Form 4 alongside backlog disclosures to spot confidence signals.
- Compare cybersecurity margin trends across periods with our Castellum Inc earnings report filing analysis dashboard.
- Set custom alerts for each Castellum Inc 8-K so material contract wins or impairment charges never slip past you.
Every filing—10-K, 10-Q, 8-K, S-1, DEF 14A, plus Castellum Inc insider trading Form 4 transactions—is updated in real time and paired with AI-powered summaries that explain filing meanings in simple terms. Skip the 300-page read and go straight to the numbers, risks, and insider moves that matter.
Castellum, Inc. (CTM) insider Form 4: A reporting person who is a Director, 10% Owner, and Officer (General Counsel, Secretary; EVP - Strategy) reported open‑market sales of common stock. The transactions were 60,000 shares on 11/11/2025 at $1.18 and 160,000 shares on 11/13/2025 at $1.165. Following these sales, the insider directly beneficially owns 7,523,973 shares.
Castellum, Inc. (CTM) reported an administrative update: the company completed a $2 million paydown and retired its note payable to Robert Eisiminger.
The update was disclosed under Other Events and includes a press release as Exhibit 99.1. This action removes that specific note obligation from the balance sheet.
Castellum, Inc. (CTM) reported an insider equity award. Chief Financial Officer David T. Bell received 225,000 stock options on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan. The options have a $1.19 exercise price and expire on November 10, 2032. They vest ratably over twenty months, beginning December 1, 2025.
Castellum (CTM) reported an insider equity grant. Chief Operating Officer Andrew Merriman was awarded 275,000 stock options on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan at an exercise price of $1.19 per share. The options vest ratably over twenty months, beginning December 1, 2025, and expire on November 10, 2032. Following the grant, 275,000 derivative securities are beneficially owned directly.
Castellum, Inc. (CTM) reported a director equity grant. On 11/11/2025, director C. Thomas McMillen was granted 100,000 stock options with an exercise price of $1.19 per share under the Second Amended 2021 Stock Incentive Plan.
The options relate to 100,000 shares of common stock, vesting ratably over twenty months commencing December 1, 2025, and expiring on 11/10/2032. Following the grant, 100,000 derivative securities were beneficially owned, held directly. The filing classifies the transaction as an acquisition of derivative securities as compensation for board service.
Castellum, Inc. (CTM) disclosed an insider equity award. Director Bernard S. Champoux was granted 100,000 stock options on 11/11/2025 with an exercise price of $1.19 per share under the Second Amended 2021 Stock Incentive Plan. The options vest ratably over twenty months starting December 1, 2025 and expire on 11/10/2032. The filing lists ownership as Direct (D). This is a routine compensation grant to a board member, not an open‑market purchase or sale.
Castellum, Inc. (CTM) reported an insider equity award. Director Mark S. Alarie received a grant of 100,000 stock options on 11/11/2025 under the Second Amended 2021 Stock Incentive Plan. The options have an exercise price of $1.19 per share and an expiration date of 11/10/2032.
The award was granted as compensation for service on the Board and vests ratably over 20 months starting December 1, 2025. Following the transaction, Mr. Alarie beneficially owned 100,000 stock options, held directly. The option grant price was recorded at $0 as an award (no purchase cost at grant).
Castellum, Inc. (CTM)Glen R. Ives received an equity award. On November 11, 2025, he was granted 500,000 stock options with an exercise price of $1.19 per share under the Second Amended 2021 Stock Incentive Plan. The options cover the right to purchase 500,000 shares of common stock, vesting ratably over twenty months starting December 1, 2025, and expiring November 10, 2032.
Castellum, Inc. (CTM)100,000 stock options granted on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan at an exercise price of $1.19 per share.
The options are exercisable for 100,000 shares of common stock, vesting ratably over twenty months starting December 1, 2025, and carry an expiration date of November 10, 2032. The grant price for the derivative security is listed as $0 at issuance, and the ownership form is direct.
CTM holder filed a Form 144 to sell up to 800,000 shares of common stock with an aggregate market value of $1,016,000, through First Georgetown Securities, with an approximate sale date of 11/11/2025 on the NYSE.
The shares were acquired on 06/12/2019 via a merger/consolidation. In the past three months, a seller named Jay Wright reported selling 1,279,700 common shares for $1,400,305 in gross proceeds.
FAQ
What is the current stock price of Castellum (CTM)?
What is the market cap of Castellum (CTM)?
